ClinicalTrials.Veeva

Menu

Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Drug: Albuterol

Study type

Interventional

Funder types

Other

Identifiers

NCT02218398
BJCYRT-002

Details and patient eligibility

About

Investigators developed a test to assess the bronchodilator effects in mechanically ventilated chronic obstructive pulmonary disease patients by comparing the change of airway resistance. No matter whether patients respond to bronchodilator or not, they are randomized assigned to bronchodilator 3-4 times per day group and no bronchodilator group. Then investigators could objectively decide whether individual patients need or benefit from bronchodilator administration.

Full description

Bronchodilator is commonly used in mechanical ventilated chronic obstructive pulmonary disease patients. It is assumed that patient's response to bronchodilator is the same during acute exacerbation or when stable whether on mechanical ventilation or not. Decision to treat is often independent of response and the patient's response to the medicine is not precisely evaluated. Investigators developed a test to assess the bronchodilator effects in mechanically ventilated chronic obstructive pulmonary disease patients by comparing the change of airway resistance. No matter whether patients respond to bronchodilator or not, they are randomized assigned to bronchodilator 3-4 times per day group and no bronchodilator group. Then investigators could objectively decide whether individual patients need or benefit from bronchodilator administration.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

should meet all the criteria:

  1. Acute exacerbated chronic obstructive pulmonary disease
  2. Invasive mechanical ventilation with intubation outside ICU no more than 48 hours

Exclusion criteria

Meet any of the criteria:

  1. Asthma
  2. Tracheotomy
  3. Prolonged Mechanical Ventilation (Have been mechanical ventilated for more than 21 days)
  4. Unstable hemodynamic status
  5. Severe pneumonia
  6. Contraindication for bronchodilator
  7. Contraindication for sedation
  8. Refusal to participate in study
  9. Re-intubation in 48 hours
  10. Mental disorder, could not understand and accomplish pulmonary function test

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

Bronchodilator
Experimental group
Description:
Albuterol 3-4 times per day, steroids when necessary.
Treatment:
Drug: Albuterol
No drug
No Intervention group
Description:
No drug

Trial contacts and locations

1

Loading...

Central trial contact

Jie Li, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems